ATYR PHARMA, INC. (ATYR) Total liabilities 2019–2025
ATYR PHARMA, INC. (ATYR) total liabilities at each fiscal year-end, per SEC filings.
$25.5MFY2025 · since FY2019: $15.0M → $25.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $25.5M | -4.8% |
| FY2024 | $26.8M | -10.6% |
| FY2023 | $30.0M | +23.3% |
| FY2022 | $24.3M | +290.0% |
| FY2021 | $6.2M | -11.9% |
| FY2020 | $7.1M | -52.8% |
| FY2019 | $15.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice